Mepolizumab Steroid-Sparing Study in Subjects With Severe Refractory Asthma

PHASE3CompletedINTERVENTIONAL
Enrollment

135

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2013

Conditions
Asthma
Interventions
DRUG

Mepolizumab

Mepolizumab is a fully humanised Immunoglobulin G antibody (IgG1, kappa) with human heavy and light chain frameworks.

DRUG

Placebo

Will be available as an equivalent volume of 0.9% sodium chloride.

DRUG

OCS (prednisone/prednisolone)

Oral Corticosteroid (prednisone/prednisolone)

Trial Locations (47)

2305

GSK Investigational Site, New Lambton

3050

GSK Investigational Site, Parkville

5042

GSK Investigational Site, Bedford Park

6009

GSK Investigational Site, Nedlands

14478

GSK Investigational Site, Potsdam

15562

GSK Investigational Site, Rüdersdorf

23552

GSK Investigational Site, Lübeck

29303

GSK Investigational Site, Spartanburg

30173

GSK Investigational Site, Hanover

34295

GSK Investigational Site, Montpellier

38610

GSK Investigational Site, Gières

44093

GSK Investigational Site, Nantes

44100

GSK Investigational Site, Guadalajara

45040

GSK Investigational Site, Zapopan

45229

GSK Investigational Site, Cincinnati

55131

GSK Investigational Site, Mainz

55905

GSK Investigational Site, Rochester

60596

GSK Investigational Site, Frankfurt am Main

63110

GSK Investigational Site, St Louis

63263

GSK Investigational Site, Neu-Isenburg

63571

GSK Investigational Site, Gelnhausen

63739

GSK Investigational Site, Aschaffenburg

67091

GSK Investigational Site, Strasbourg

75877

GSK Investigational Site, Paris

80206

GSK Investigational Site, Denver

90808

GSK Investigational Site, Long Beach

06520

GSK Investigational Site, New Haven

PA 15213

GSK Investigational Site, Pittsburgh

L8N 4A6

GSK Investigational Site, Hamilton

H2X 2P4

GSK Investigational Site, Montreal

H4J 1C5

GSK Investigational Site, Montreal

G1V 4G5

GSK Investigational Site, Québec

625 00

GSK Investigational Site, Brno

775 20

GSK Investigational Site, Olomouc

140 59

GSK Investigational Site, Prague

180 01

GSK Investigational Site, Prague

1105 AZ

GSK Investigational Site, Amsterdam

8934 AD

GSK Investigational Site, Leeuwarden

3045 PM

GSK Investigational Site, Rotterdam

15-010

GSK Investigational Site, Bialystok

15-044

GSK Investigational Site, Bialystok

31-024

GSK Investigational Site, Krakow

90-153

GSK Investigational Site, Lodz

LE3 9QP

GSK Investigational Site, Leicester

L9 7AL

GSK Investigational Site, Liverpool

NE1 4LP

GSK Investigational Site, Newcastle upon Tyne

SO16 6YD

GSK Investigational Site, Southampton

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY